HEALTHJun 11 · 18:33 UTCSTAT NEWSLauren Chan

Nonprofit buys experimental cancer drug to maintain patient access

Nonprofit Blood Cancer United acquired discontinued experimental cancer drug Luvelta to maintain patient access, managing a compassionate-use program for children with a rare blood cancer and distributing the medication at no cost while supplies last.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Blood Cancer UnitedorganizationLeukemia & Lymphoma SocietyorganizationLuveltatopiccompassionate-use programtopicblood cancertopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 30 · 13:25 UTC
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
HEALTHJun 9 · 13:38 UTC
GSK buys cancer drugmaker Nuvalent for $10B
HEALTHMay 27 · 13:33 UTC
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
HEALTHMay 7 · 12:00 UTC
STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection
HEALTHMay 7 · 13:23 UTC
STAT+: FDA to reconsider treatment for rare cancer after surprise rejection